B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MDH2

MOLECULAR TARGET

malate dehydrogenase 2

UniProt: P40926NCBI Gene: 41911 compounds

MDH2 (malate dehydrogenase 2) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MDH2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Sorafenib1.102

About MDH2 as a Drug Target

MDH2 (malate dehydrogenase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented MDH2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MDH2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.